Neue Therapiekonzepte bei der chronisch-lymphatischen Leukämie View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-04

AUTHORS

Barbara Eichhorst, Michael Hallek

ABSTRACT

Die chronisch-lymphatische Leukämie (CLL) ist die häufigste Leukämieform in der westlichen Welt und betrifft v. a. männliche sowie ältere Patienten. Trotz großer Fortschritte bei der Behandlung im fortgeschrittenen symptomatischen Stadium ist die Erkrankung nicht kurativ behandelbar. Die Therapie richtet sich nach der Fitness sowie Begleiterkrankungen und Vorhandensein einer Veränderung des TP53-Gens (Höchstrisiko-CLL). Für körperlich fitte Patienten ohne Höchstrisiko kommen intensivere Kombinationen aus Chemotherapie und CD20-Antikörper infrage, für ältere und/oder komorbide Patienten weniger intensive Therapien. Für Patienten mit Höchstrisiko-CLL sowie für die rezidivierte CLL stehen 2 orale Kinaseinhibitoren, die den Signaltransduktionsweg des B‑Zell-Rezeptors blockieren, zur Verfügung. Im Rezidiv kann alternativ nach an einer lang anhaltenden ersten Remission auch eine Chemoimmuntherapie wiederholt werden. Die allogene Stammzelltransplantation wird unter Abschätzung des Transplantationsrisikos v. a. bei Hochrisiko-CLL und nicht ausreichendem Ansprechen auf Kinaseinhibitoren erwogen. More... »

PAGES

283-294

Journal

TITLE

Der Onkologe

ISSUE

4

VOLUME

22

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00761-016-0024-6

DOI

http://dx.doi.org/10.1007/s00761-016-0024-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032920258


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Cologne", 
          "id": "https://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Klinik I f\u00fcr Innere Medizin, Centrum f\u00fcr Integrierte Onkologie K\u00f6ln Bonn, Universit\u00e4t K\u00f6ln, Kerpener Str.\u00a062, 50924, K\u00f6ln, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eichhorst", 
        "givenName": "Barbara", 
        "id": "sg:person.01167624730.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167624730.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cologne", 
          "id": "https://www.grid.ac/institutes/grid.6190.e", 
          "name": [
            "Klinik I f\u00fcr Innere Medizin, Centrum f\u00fcr Integrierte Onkologie K\u00f6ln Bonn, Universit\u00e4t K\u00f6ln, Kerpener Str.\u00a062, 50924, K\u00f6ln, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hallek", 
        "givenName": "Michael", 
        "id": "sg:person.01025161256.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025161256.58"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1400376", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005487964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2007-06-093906", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006649234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-03-275420", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009414333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-10-606038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011356913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1109016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012874418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1313984", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014014595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)61381-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016656695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2015.14", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018320802", 
          "https://doi.org/10.1038/leu.2015.14"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.2688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022703461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-07-586826", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023267831"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa075290", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024267663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1315226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032214328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70513-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034511288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036959406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428199609054782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038473954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(15)60027-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038838231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.semcancer.2013.06.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042109829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1215637", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047519052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200012283432602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051287807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2012.216", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052508507", 
          "https://doi.org/10.1038/leu.2012.216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-02-556399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052522865"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074517562", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074517563", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074829732", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083076559", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-04", 
    "datePublishedReg": "2016-04-01", 
    "description": "Die chronisch-lymphatische Leuk\u00e4mie (CLL) ist die h\u00e4ufigste Leuk\u00e4mieform in der westlichen Welt und betrifft v. a. m\u00e4nnliche sowie \u00e4ltere Patienten. Trotz gro\u00dfer Fortschritte bei der Behandlung im fortgeschrittenen symptomatischen Stadium ist die Erkrankung nicht kurativ behandelbar. Die Therapie richtet sich nach der Fitness sowie Begleiterkrankungen und Vorhandensein einer Ver\u00e4nderung des TP53-Gens (H\u00f6chstrisiko-CLL). F\u00fcr k\u00f6rperlich fitte Patienten ohne H\u00f6chstrisiko kommen intensivere Kombinationen aus Chemotherapie und CD20-Antik\u00f6rper infrage, f\u00fcr \u00e4ltere und/oder komorbide Patienten weniger intensive Therapien. F\u00fcr Patienten mit H\u00f6chstrisiko-CLL sowie f\u00fcr die rezidivierte CLL stehen 2 orale Kinaseinhibitoren, die den Signaltransduktionsweg des B\u2011Zell-Rezeptors blockieren, zur Verf\u00fcgung. Im Rezidiv kann alternativ nach an einer lang anhaltenden ersten Remission auch eine Chemoimmuntherapie wiederholt werden. Die allogene Stammzelltransplantation wird unter Absch\u00e4tzung des Transplantationsrisikos v. a. bei Hochrisiko-CLL und nicht ausreichendem Ansprechen auf Kinaseinhibitoren erwogen.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00761-016-0024-6", 
    "inLanguage": [
      "de"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1119546", 
        "issn": [
          "0947-8965", 
          "1433-0415"
        ], 
        "name": "Der Onkologe", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Neue Therapiekonzepte bei der chronisch-lymphatischen Leuk\u00e4mie", 
    "pagination": "283-294", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9cd3ed334b52d078b5d59a4c4932496052984bbedf7ed84c001f1a2dd16ecd87"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00761-016-0024-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032920258"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00761-016-0024-6", 
      "https://app.dimensions.ai/details/publication/pub.1032920258"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000533.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00761-016-0024-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00761-016-0024-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00761-016-0024-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00761-016-0024-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00761-016-0024-6'


 

This table displays all metadata directly associated to this object as RDF triples.

133 TRIPLES      20 PREDICATES      50 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00761-016-0024-6 schema:author Na3366381c8174e6891ab70e348b9ebec
2 schema:citation sg:pub.10.1038/leu.2012.216
3 sg:pub.10.1038/leu.2015.14
4 https://app.dimensions.ai/details/publication/pub.1074517562
5 https://app.dimensions.ai/details/publication/pub.1074517563
6 https://app.dimensions.ai/details/publication/pub.1074829732
7 https://app.dimensions.ai/details/publication/pub.1083076559
8 https://doi.org/10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v
9 https://doi.org/10.1016/j.semcancer.2013.06.010
10 https://doi.org/10.1016/s0140-6736(10)61381-5
11 https://doi.org/10.1016/s0140-6736(15)60027-7
12 https://doi.org/10.1016/s1470-2045(13)70513-8
13 https://doi.org/10.1056/nejm200012283432602
14 https://doi.org/10.1056/nejmoa075290
15 https://doi.org/10.1056/nejmoa1109016
16 https://doi.org/10.1056/nejmoa1215637
17 https://doi.org/10.1056/nejmoa1313984
18 https://doi.org/10.1056/nejmoa1315226
19 https://doi.org/10.1056/nejmoa1400376
20 https://doi.org/10.1182/blood-2007-06-093906
21 https://doi.org/10.1182/blood-2010-03-275420
22 https://doi.org/10.1182/blood-2014-02-556399
23 https://doi.org/10.1182/blood-2014-07-586826
24 https://doi.org/10.1182/blood-2014-10-606038
25 https://doi.org/10.1200/jco.2011.39.2688
26 https://doi.org/10.3109/10428199609054782
27 schema:datePublished 2016-04
28 schema:datePublishedReg 2016-04-01
29 schema:description Die chronisch-lymphatische Leukämie (CLL) ist die häufigste Leukämieform in der westlichen Welt und betrifft v. a. männliche sowie ältere Patienten. Trotz großer Fortschritte bei der Behandlung im fortgeschrittenen symptomatischen Stadium ist die Erkrankung nicht kurativ behandelbar. Die Therapie richtet sich nach der Fitness sowie Begleiterkrankungen und Vorhandensein einer Veränderung des TP53-Gens (Höchstrisiko-CLL). Für körperlich fitte Patienten ohne Höchstrisiko kommen intensivere Kombinationen aus Chemotherapie und CD20-Antikörper infrage, für ältere und/oder komorbide Patienten weniger intensive Therapien. Für Patienten mit Höchstrisiko-CLL sowie für die rezidivierte CLL stehen 2 orale Kinaseinhibitoren, die den Signaltransduktionsweg des B‑Zell-Rezeptors blockieren, zur Verfügung. Im Rezidiv kann alternativ nach an einer lang anhaltenden ersten Remission auch eine Chemoimmuntherapie wiederholt werden. Die allogene Stammzelltransplantation wird unter Abschätzung des Transplantationsrisikos v. a. bei Hochrisiko-CLL und nicht ausreichendem Ansprechen auf Kinaseinhibitoren erwogen.
30 schema:genre research_article
31 schema:inLanguage de
32 schema:isAccessibleForFree false
33 schema:isPartOf N77536272133441a5aa5d9943dc7cfdbb
34 N9a57d352bd4a44269dfe66b864b0c11b
35 sg:journal.1119546
36 schema:name Neue Therapiekonzepte bei der chronisch-lymphatischen Leukämie
37 schema:pagination 283-294
38 schema:productId N9d831f97fe3d451c9b86c5bd51c7642a
39 Nb0a504d3cfa3427a9d9a5cb0eeca27e5
40 Nedc87cb3e04043898438fd0c18b0266c
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032920258
42 https://doi.org/10.1007/s00761-016-0024-6
43 schema:sdDatePublished 2019-04-10T15:55
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher Neca99631004947738ae741e6f6181be7
46 schema:url http://link.springer.com/10.1007%2Fs00761-016-0024-6
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N77536272133441a5aa5d9943dc7cfdbb schema:issueNumber 4
51 rdf:type schema:PublicationIssue
52 N9a57d352bd4a44269dfe66b864b0c11b schema:volumeNumber 22
53 rdf:type schema:PublicationVolume
54 N9d831f97fe3d451c9b86c5bd51c7642a schema:name doi
55 schema:value 10.1007/s00761-016-0024-6
56 rdf:type schema:PropertyValue
57 Na3366381c8174e6891ab70e348b9ebec rdf:first sg:person.01167624730.99
58 rdf:rest Nfd7f21f68d8a4456a8f230879aba37d6
59 Nb0a504d3cfa3427a9d9a5cb0eeca27e5 schema:name readcube_id
60 schema:value 9cd3ed334b52d078b5d59a4c4932496052984bbedf7ed84c001f1a2dd16ecd87
61 rdf:type schema:PropertyValue
62 Neca99631004947738ae741e6f6181be7 schema:name Springer Nature - SN SciGraph project
63 rdf:type schema:Organization
64 Nedc87cb3e04043898438fd0c18b0266c schema:name dimensions_id
65 schema:value pub.1032920258
66 rdf:type schema:PropertyValue
67 Nfd7f21f68d8a4456a8f230879aba37d6 rdf:first sg:person.01025161256.58
68 rdf:rest rdf:nil
69 sg:journal.1119546 schema:issn 0947-8965
70 1433-0415
71 schema:name Der Onkologe
72 rdf:type schema:Periodical
73 sg:person.01025161256.58 schema:affiliation https://www.grid.ac/institutes/grid.6190.e
74 schema:familyName Hallek
75 schema:givenName Michael
76 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025161256.58
77 rdf:type schema:Person
78 sg:person.01167624730.99 schema:affiliation https://www.grid.ac/institutes/grid.6190.e
79 schema:familyName Eichhorst
80 schema:givenName Barbara
81 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167624730.99
82 rdf:type schema:Person
83 sg:pub.10.1038/leu.2012.216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052508507
84 https://doi.org/10.1038/leu.2012.216
85 rdf:type schema:CreativeWork
86 sg:pub.10.1038/leu.2015.14 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018320802
87 https://doi.org/10.1038/leu.2015.14
88 rdf:type schema:CreativeWork
89 https://app.dimensions.ai/details/publication/pub.1074517562 schema:CreativeWork
90 https://app.dimensions.ai/details/publication/pub.1074517563 schema:CreativeWork
91 https://app.dimensions.ai/details/publication/pub.1074829732 schema:CreativeWork
92 https://app.dimensions.ai/details/publication/pub.1083076559 schema:CreativeWork
93 https://doi.org/10.1002/1097-0142(19810701)48:1<198::aid-cncr2820480131>3.0.co;2-v schema:sameAs https://app.dimensions.ai/details/publication/pub.1036959406
94 rdf:type schema:CreativeWork
95 https://doi.org/10.1016/j.semcancer.2013.06.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042109829
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1016/s0140-6736(10)61381-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016656695
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1016/s0140-6736(15)60027-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038838231
100 rdf:type schema:CreativeWork
101 https://doi.org/10.1016/s1470-2045(13)70513-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034511288
102 rdf:type schema:CreativeWork
103 https://doi.org/10.1056/nejm200012283432602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051287807
104 rdf:type schema:CreativeWork
105 https://doi.org/10.1056/nejmoa075290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024267663
106 rdf:type schema:CreativeWork
107 https://doi.org/10.1056/nejmoa1109016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012874418
108 rdf:type schema:CreativeWork
109 https://doi.org/10.1056/nejmoa1215637 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047519052
110 rdf:type schema:CreativeWork
111 https://doi.org/10.1056/nejmoa1313984 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014014595
112 rdf:type schema:CreativeWork
113 https://doi.org/10.1056/nejmoa1315226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032214328
114 rdf:type schema:CreativeWork
115 https://doi.org/10.1056/nejmoa1400376 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005487964
116 rdf:type schema:CreativeWork
117 https://doi.org/10.1182/blood-2007-06-093906 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006649234
118 rdf:type schema:CreativeWork
119 https://doi.org/10.1182/blood-2010-03-275420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009414333
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1182/blood-2014-02-556399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052522865
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1182/blood-2014-07-586826 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023267831
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1182/blood-2014-10-606038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011356913
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1200/jco.2011.39.2688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022703461
128 rdf:type schema:CreativeWork
129 https://doi.org/10.3109/10428199609054782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038473954
130 rdf:type schema:CreativeWork
131 https://www.grid.ac/institutes/grid.6190.e schema:alternateName University of Cologne
132 schema:name Klinik I für Innere Medizin, Centrum für Integrierte Onkologie Köln Bonn, Universität Köln, Kerpener Str. 62, 50924, Köln, Deutschland
133 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...